Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF STOCK OPTION ACTIVITY (Details)

v3.21.2
SUMMARY OF STOCK OPTION ACTIVITY (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2021
Dec. 31, 2020
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]      
Option outstanding, balance   468,619  
Weighted average exercise price outstanding, balance   $ 1.31  
Option granted   644,000  
Weighted average exercise price, granted   $ 0.36  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance 1,112,619 1,112,619 468,619
Weighted average exercise price outstanding, balance $ 0.76 $ 0.76 $ 1.31
Option outstanding exercisable 468,619 468,619  
Officers and Directors [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]      
Weighted average remaining contractual term outstanding   7 years 9 months 18 days 5 years 7 months 6 days
Aggregate Intrinsic Value, Beginning balance    
Option granted 644,000    
Weighted average exercise price, granted $ 0.36    
Weighted average remaining contractual term outstanding, granted     9 years 10 months 24 days
Aggregate instrinsic value, granted    
Aggregate Intrinsic Value, Ending Balance
Weighted average remaining contractual term outstanding, exercisable   4 years 10 months 24 days  
Aggregate Intrinsic Value, Exercisable